Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Med Chem ; 164: 391-398, 2019 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-30611980

RESUMEN

Although pediatric leukemia is generally treatable, certain leukemic subtypes face poor prognosis in the clinic suggesting new selective therapeutic agents are needed. Thus, to identify selective apoptosis inducers, a small-molecule library screening approach was conducted using an isogenic leukemic murine p185+ B-ALL cell line pair (BCR-ABL-WT and the BAX/BAK deficient BCR-ABL-DKO). Gratifyingly, the investigation revealed several compounds featuring substituted aromatic five-membered-ring heterocycles with significant activity against murine and human leukemic cellular models. The identified compounds represent potentially novel antileukemic molecular scaffolds exemplified by compounds 1, 2 and 7, which demonstrated EC50 values in the nanomolar and low micromolar range against various leukemia subtypes (SUP-B15, KOPN-8, NALM-06, UoC-B1 cellular models) and pro-apoptotic properties in solid tumor cell models (MDA-MB-231, SUM149) with ample therapeutic index in normal cells. Herein, we highlight compounds 1, 2 and 7 which promote cell death mediated by caspase 3/7 induction. Our study establishes a strategic platform for the development of potent and selective anti-leukemic agents.


Asunto(s)
Antineoplásicos/farmacología , Compuestos Heterocíclicos/uso terapéutico , Leucemia/tratamiento farmacológico , Animales , Antineoplásicos/química , Apoptosis/efectos de los fármacos , Caspasas/genética , Línea Celular Tumoral , Evaluación Preclínica de Medicamentos/métodos , Inducción Enzimática/efectos de los fármacos , Compuestos Heterocíclicos/química , Humanos , Ratones , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Índice Terapéutico
2.
Molecules ; 19(1): 756-66, 2014 Jan 08.
Artículo en Inglés | MEDLINE | ID: mdl-24406786

RESUMEN

Over 216 million malaria cases are reported annually worldwide and about a third of these cases, primarily children under the age of five years old, will not survive the infection. Despite this significant world health impact, only a limited number of therapeutic agents are currently available. The lack of scaffold diversity poses a threat in the event that multi-drug-resistant strains emerge. Terrestrial natural products have provided a major source of chemical diversity for starting materials in many FDA approved drugs over the past century. Bixa orellana L. is a popular plant used in South America for the treatment of malaria. In search of new potential therapeutic agents, the chemical constituents of a selected hairy root culture line of Bixa orellana L. were characterized utilizing NMR and mass spectrometry methods, followed by its biological evaluation against malaria strains 3D7 and K1. The crude extract and its isolated compounds demonstrated EC50 values in the micromolar range. Herein, we report our findings on the chemical constituents of Bixa orellana L. from hairy roots responsible for the observed antimalarial activity.


Asunto(s)
Antimaláricos/química , Antimaláricos/farmacología , Bixaceae/química , Extractos Vegetales/química , Extractos Vegetales/farmacología , Raíces de Plantas/química , Antimaláricos/toxicidad , Línea Celular , Ciclopentanos/química , Humanos , Isomerismo , Estructura Molecular , Oxilipinas/química , Pruebas de Sensibilidad Parasitaria , Extractos Vegetales/toxicidad
3.
Bioorg Med Chem Lett ; 13(19): 3217-21, 2003 Oct 06.
Artículo en Inglés | MEDLINE | ID: mdl-12951096

RESUMEN

The synthesis and biological evaluation of a new family of diterpenes, represented by structures 2 and 3, is presented. These compounds constitute isomeric analogues of acanthoic acid (1) and were examined as potent anti-inflammatory agents. Among them, methyl ester 12 exhibited a low non-specific cytotoxicity, inhibited TNF-alpha synthesis and displayed good specificity in suppressing cytokine expression.


Asunto(s)
Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/farmacología , Diterpenos/síntesis química , Diterpenos/farmacología , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Eleutherococcus , Humanos , Extractos Vegetales/síntesis química , Extractos Vegetales/farmacología , Raíces de Plantas , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA